María Angeles Pérez Saenz

María Angeles Pérez Saenz

MEDICO ESPECIALISTA EN HEMATOLOGIA
Especialidad:
Hematología y Hemoterapia
Especialidades:
  • Hematología y Hemoterapia
Hospital / Centro:
  • Hospital Universitario Fundación Jiménez Díaz
Información general
Experiencia

1997 - 2009 FACULTATIVO ESPECIALISTA / HOSPITAL CLINICA MONCLOA

1995 - 1997 FACULTATIVO ESPECIALISTA / CLINICA RUBER

1992 - 1994 FACULTATIVO ESPECIALISTA / HOSPITAL UNIVERSITARIO GENERAL GREGORIO MARAÑON

1991 - 1991 FACULTATIVO ESPECIALISTA / FUNDACION JIMENEZ DIAZ-UTE

Titulación

DOCTORA EN MEDICINA POR LA UNIVERDIDAD AUTONOMA DE MADRID

MEDICO ESPECIALISTA EN HEMATOLOGIA Y HEMOTERAPIA

Compañías aseguradoras
  • AEGON
  • ADESLAS
  • AGRUPACION ANFI
  • ASISA
  • AXA SEGUROS GENERALES
  • CATALANA OCCIDENTE
  • CASER
  • CIGNA
  • DIVINA PASTORA
  • DKV
  • GENERALI
  • HERMANDAD NACIONAL DE ARQUITECTOS (HNA)
  • MAPFRE
  • MUSA
  • UNIÓN MADRILEÑA
  • PRIVADOS
Técnicas

ACTIVIDAD CLINICA DE PREFERENCIA EN CONSULTA EXTERNA

Investigación y docencia

INVESTIGACION EN CONTEXTO DE ENSAYOS CLINICOS

Publicaciones

1- Civallero M, Schroers-Martin JG, Horwitz S, Manni M, Stepanishyna Y, Cabrera ME, Vose J, Spina M, Hitz F, Nagler A, Montoto S, Chiattone C, Skrypets T, Perez Saenz MA, Priolo G, Luminari S, Lymboussaki A, Pavlovsky A, Marino D, Liberati M, Trotman J, Mannina D, Federico M, Advani R. Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project. Br J Haematol. 2024 Jul;205(1):166-174. doi: 10.1111/bjh.19433. Epub 2024 Mar 26

2-Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy. López-Nevado M, Ortiz-Martín J, Serrano C, Pérez-Saez MA, López-Lorenzo JL, Gil-Etayo FJ, Rodríguez-Frías E, Cabrera-Marante O, Morales-Pérez P, Rodríguez-Pinilla MS, Manso R, Salgado-Sánchez RN, Cerdá-Montagud A, Quesada-Espinosa JF, Gómez-Rodríguez MJ, Paz-Artal E, Muñoz-Calleja C, Arranz-Sáez R, Allende LM.J Clin Immunol. 2023 Jan;43(1):165-180. doi: 10.1007/s10875-022-01361-y. Epub 2022 Sep 6.PMID: 36066697

3-Feasibility of Telemedicine in the Management Strategy of Patients With Lymphoma Amid the COVID-19 Pandemic in Spain: Prospective Observational Study. Cordoba R, Lopez-Garcia A, Morillo D, Perez-Saenz MA, Askari E, Prieto RE, Castillo Bazan E, Llamas Sillero P, Herrero Gonzalez A, Short Apellaniz J, Del Olmo M, Arcos J.JMIR Form Res. 2023 Nov 17;7:e34128. doi: 10.2196/34128

4-Pérez-Sáenz MA; Rodriguez-Pinilla MS; Salgado RN;Alonso-Dominguez JM. 2020. Three monocytic neoplasms in a single patient LeukLymphoma.61-10, pp.2523-2526

5- Santonja C; Carrasco L; Perez-Saenz MLA; Loreto Carrasco; Rodriguez-Pinilla SM. 2020. A Skin Plaque Preceding Systemic Relapse of Gamma-Delta Hepatosplenic T-Cell Lymphoma.Am J Dermatopathol. 42-5, pp.364-367.

6- Santonja C. 2020. -T-Cell-Rich Recurrence of Primary Cutaneous Follicle Center Lymphoma After Systemic Rituximab Am J Dermatopathol. 42-3, pp.36-40.

7- Manso R; Roncador G; Montes-Moreno S; Rojo F; Pérez-Saenz MA; Rodriguez-Pinilla MS. 2017. -p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients Br J Haematol. 176-4, pp.661-664.

8- Gomez-Leon N; Delgado-Bolton R; Cabezas B; Campo del Val L; Arranz R; Cannata J; Perez-Saenz MA; Gonzalez-Ortega S. 2017. Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi–Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma Clin Nuc Med. 42, pp.595-602.

9-Plaza C; Yuste M; Zheng B; Pérez-Saenz MA. Diffuse large B cell Lymphoma: On overview of the disease with especial focus on CIRS scale and Emergency visits in the elderly population.J Geriatr Oncolo. 7-6, pp.559.